Hepatitis C testing
Diagnostic TestHepatitis C Screening
NCT Number: NCT04405024
The Ministry of Health has set the target of eradicating hepatitis C (HCV) in France by 2025.
The goal is to validate the feasibility and value of conducting routine HCV screening in hospitalized patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
CHI Créteil, Créteil, France
The number of undetected HCV-infected persons has been extrapolated to 75,000 according to the results of a 2014 study. Screening efforts have been set up in groups of people said to be at high viral risk: drug users, prisoners, precarious persons or migrants from highly endemic countries. Nevertheless, the concept of universal screening has not yet been adopted by the guardians and the Ministry.
It is in this context that "hepatitis free hospital" projects have been carried out in several French cities such as Nice, Nancy and Marseille.
The aim of the HOSPI-VHC study is to evaluate the feasibility and efficiency of systematic HCV screening in all medical and surgical departments of 4 National Association of Hepato-Gastroenterologists of General Hospitals (ANGH) hospitals. This pilot project is part of a public health screening program. It will evaluate the interest and usefulness of implementing universal screening in hospitalized patients without taking into account the existence of viral risk factors. This study will also make it possible to evaluate the implementation of a dedicated care pathway: number of patients screened, number of patients referred for consultation and number of patients accepting the consultation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hepatitis C Screening
Time frame: 7 days
Number of HCV serologies collected compared to the number of patients meeting the inclusion criteria during the study period.
Time frame: 7 days
Percentage positive for HCV
Time frame: 2 months
Percentage of patients referred for consultation if HCV positive
Time frame: 7 days
Percentage of HCV PCR positive patients
Time frame: 7 days
Percentage of patients with a viral risk factor
Time frame: 7 days
Percentage of patients with hepatic fibrosis
Time frame: 2 months
Percentage of patients benefiting from treatment initiation
Looking for future studies?
Notify MeCentre Hospitalier Intercommunal Creteil
Other
Pilot Study of the Feasibility of Routine Inpatient Hepatitis C Screening
Acronym: HOSPI-VHC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07237282
Blood-Borne Infections, Communicable Diseases
Edmonton, Alberta, Canada
View Trial DetailsNCT00001971
Blood-Borne Infections, Chronic Disease
Bethesda, Maryland, United States
View Trial DetailsNCT00004850
Blood-Borne Infections, Communicable Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04961723
Behavior, Blood-Borne Infections
Batumi, Georgia
View Trial Details